CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Amedisys - AMED CFD

Market is not available at the moment

Market information is presented
as of 2023-09-21

  • Summary
Trading Conditions
Spread 0.23
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Amedisys Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 109.56
Open* 109.3
1-Year Change* -0.65%
Day's Range* 106.57 - 111.92
52 wk Range 69.37-126.81
Average Volume (10 days) 579.14K
Average Volume (3 months) 9.52M
Market Cap 3.03B
P/E Ratio 1,341.17
Shares Outstanding 32.63M
Revenue 2.23B
EPS 0.07
Dividend (Yield %) N/A
Beta 1.00
Next Earnings Date Oct 24, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Date Close Change Change (%) Open High Low
Jun 29, 2022 109.98 0.67 0.61% 109.31 112.01 106.23
Jun 28, 2022 109.56 -3.02 -2.68% 112.58 114.45 109.51
Jun 27, 2022 114.51 -2.68 -2.29% 117.19 117.59 111.22
Jun 24, 2022 115.50 4.81 4.35% 110.69 116.12 110.41
Jun 23, 2022 115.18 6.07 5.56% 109.11 115.42 107.94
Jun 22, 2022 108.44 1.67 1.56% 106.77 111.76 106.13
Jun 21, 2022 107.29 -2.66 -2.42% 109.95 109.95 101.37
Jun 17, 2022 121.29 6.53 5.69% 114.76 122.49 114.76
Jun 16, 2022 115.50 5.49 4.99% 110.01 116.23 110.01
Jun 15, 2022 115.84 6.59 6.03% 109.25 117.57 109.25
Jun 14, 2022 110.93 0.43 0.39% 110.50 112.49 109.22
Jun 13, 2022 111.44 -0.48 -0.43% 111.92 118.67 110.64
Jun 10, 2022 119.95 7.51 6.68% 112.44 120.29 112.42
Jun 9, 2022 114.91 4.56 4.13% 110.35 115.90 110.35
Jun 8, 2022 115.53 0.50 0.43% 115.03 118.23 114.28
Jun 7, 2022 115.06 2.40 2.13% 112.66 115.98 111.04
Jun 6, 2022 114.59 -0.59 -0.51% 115.18 117.76 114.09
Jun 3, 2022 115.04 1.82 1.61% 113.22 115.66 112.80
Jun 2, 2022 116.10 0.76 0.66% 115.34 117.20 113.67
Jun 1, 2022 115.48 -0.59 -0.51% 116.07 117.85 113.76

Amedisys Events

Time (UTC) Country Event
Tuesday, October 24, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Amedisys Inc Earnings Release
Q3 2023 Amedisys Inc Earnings Release

Forecast

-

Previous

-
Tuesday, February 13, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Amedisys Inc Earnings Release
Q4 2023 Amedisys Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2223.2 2214.11 2071.52 1955.63 1662.58
Revenue 2223.2 2214.11 2071.52 1955.63 1662.58
Cost of Revenue, Total 1251.43 1199.39 1185.37 1150.34 992.863
Gross Profit 971.774 1014.72 886.15 805.296 669.715
Total Operating Expense 2042.43 1962.2 1852.25 1778.16 1508.43
Selling/General/Admin. Expenses, Total 754.058 711.24 668.3 607.926 501.306
Depreciation / Amortization 24.935 30.901 28.802 18.428 13.261
Unusual Expense (Income) 12.009 20.667 -30.22 1.47 1
Operating Income 180.772 251.915 219.268 177.472 154.148
Interest Income (Expense), Net Non-Operating -22.095 26.571 -6.78 -9.099 0.6
Other, Net 1.567 1.745 -1.669 2.037 4.24
Net Income Before Taxes 160.244 280.231 210.819 170.41 158.988
Net Income After Taxes 117.699 210.166 185.184 127.907 120.129
Minority Interest 0.91 -1.094 -1.576 -1.074 -0.783
Net Income Before Extra. Items 118.609 209.072 183.608 126.833 119.346
Net Income 118.609 209.072 183.608 126.833 119.346
Income Available to Common Excl. Extra. Items 118.609 209.072 183.608 126.833 119.346
Income Available to Common Incl. Extra. Items 118.609 209.072 183.608 126.833 119.346
Diluted Net Income 118.609 209.072 183.608 126.833 119.346
Diluted Weighted Average Shares 32.653 32.972 33.268 32.99 33.609
Diluted EPS Excluding Extraordinary Items 3.63241 6.3409 5.51906 3.84459 3.55101
Diluted Normalized EPS 3.96102 6.836 5.05118 4.26507 3.57349
Total Extraordinary Items
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 552.968 556.389 562.064 557.988 557.89
Revenue 552.968 556.389 562.064 557.988 557.89
Cost of Revenue, Total 297.455 315.01 316.167 318.227 313.211
Gross Profit 255.513 241.379 245.897 239.761 244.679
Total Operating Expense 621.173 514.01 515.826 519.057 510.249
Selling/General/Admin. Expenses, Total 212.993 194.557 193.429 188.344 187.818
Depreciation / Amortization 4.725 4.443 5.23 5.477 6.22
Unusual Expense (Income) 106 1 7.009 3
Operating Income -68.205 42.379 46.238 38.931 47.641
Interest Income (Expense), Net Non-Operating 1.231 -6.988 -5.314 -4.602 -7.616
Other, Net 4.743 -0.682 0.412 0.491 0.331
Net Income Before Taxes -62.231 34.709 41.336 34.82 40.356
Net Income After Taxes -80.481 24.909 31.546 25.403 29.037
Minority Interest 0.206 0.337 0.171 0.239 0.542
Net Income Before Extra. Items -80.275 25.246 31.717 25.642 29.579
Net Income -80.275 25.246 31.717 25.642 29.579
Income Available to Common Excl. Extra. Items -80.275 25.246 31.717 25.642 29.579
Income Available to Common Incl. Extra. Items -80.275 25.246 31.717 25.642 29.579
Diluted Net Income -80.275 25.246 31.717 25.642 29.579
Diluted Weighted Average Shares 32.579 32.643 32.572 32.616 32.681
Diluted EPS Excluding Extraordinary Items -2.46401 0.7734 0.97375 0.78618 0.90508
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.34915 0.7734 0.99718 0.94296 0.97113
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 388.961 356.684 361.984 350.554 224.118
Cash and Short Term Investments 40.54 42.694 81.808 30.294 20.229
Cash & Equivalents 40.54 42.694 81.808 30.294 20.229
Total Receivables, Net 309.185 287.061 259.845 241.596 192.472
Accounts Receivable - Trade, Net 300.385 278.861 259.645 239.596 190.872
Prepaid Expenses 11.628 10.356 10.217 8.243 7.568
Other Current Assets, Total 27.608 16.573 10.114 70.421 3.849
Total Assets 1976.24 1856.97 1567.2 1262.74 717.118
Property/Plant/Equipment, Total - Net 118.882 119.692 117.159 112.904 29.449
Property/Plant/Equipment, Total - Gross 220.246 216.629 212.183 209.041 124.921
Accumulated Depreciation, Total -101.364 -96.937 -95.024 -96.137 -95.472
Goodwill, Net 1287.4 1196.09 932.685 658.5 329.48
Intangibles, Net 101.167 111.19 74.183 64.748 44.132
Long Term Investments 60.5 53.1 14.2 35.7 35.1
Other Long Term Assets, Total 19.336 20.212 66.987 40.339 54.839
Total Current Liabilities 355.529 374.282 456.337 326.943 222.476
Accounts Payable 43.735 38.217 42.674 31.259 28.531
Accrued Expenses 296.298 323.07 343.167 285.757 192.333
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 15.496 12.995 10.496 9.927 1.612
Total Liabilities 924.672 925.617 757.974 622.295 235.536
Total Long Term Debt 419.42 432.075 204.511 232.256 5.775
Long Term Debt 418.32 431.375 203.611 230.556 5.775
Minority Interest 55 44.972 1.517 1.063 1.051
Other Liabilities, Total 74.312 74.288 95.609 62.033 6.234
Total Equity 1051.57 931.351 809.224 640.45 481.582
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.038 0.038 0.038 0.037 0.036
Additional Paid-In Capital 755.063 728.118 698.287 645.256 603.666
Retained Earnings (Accumulated Deficit) 757.672 639.063 429.991 246.383 119.55
Treasury Stock - Common -461.2 -435.868 -319.092 -251.241 -241.685
Other Equity, Total 0 0.015 0.015
Total Liabilities & Shareholders’ Equity 1976.24 1856.97 1567.2 1262.74 717.118
Total Common Shares Outstanding 32.5183 32.51 32.8143 32.284 31.9735
Capital Lease Obligations 1.1 0.7 0.9 1.7
Other Current Liabilities, Total 0 60
Deferred Income Tax 20.411
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 405.557 388.961 388.78 394.869 392.485
Cash and Short Term Investments 49.436 40.54 17.956 26.566 67.834
Cash & Equivalents 49.436 40.54 17.956 26.566 67.834
Total Receivables, Net 294.122 296.785 302.47 305.413 293.579
Accounts Receivable - Trade, Net 294.122 296.785 302.47 305.413 293.579
Prepaid Expenses 18.754 11.628 17.011 15.199 17.221
Other Current Assets, Total 43.245 40.008 51.343 47.691 13.851
Total Assets 1946.96 1976.24 1982.13 2000.99 1908.39
Property/Plant/Equipment, Total - Net 118.564 118.882 123.091 125.57 120.096
Property/Plant/Equipment, Total - Gross 138.536 117.39 119.655 118.112 115.868
Accumulated Depreciation, Total -105.183 -101.364 -102.407 -100.265 -98.573
Goodwill, Net 1244.68 1287.4 1285.45 1289.67 1204.64
Intangibles, Net 99.929 101.167 103.678 106.189 106.534
Long Term Investments 58.9 60.5 61.5 65 65
Other Long Term Assets, Total 19.33 19.336 19.623 19.686 19.639
Total Current Liabilities 353.05 355.529 367.2 427.372 380.154
Accounts Payable 40.017 43.735 45.527 43.509 36.621
Accrued Expenses 286.075 296.298 309.045 371.342 331.224
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 26.958 15.496 12.628 12.521 12.309
Other Current Liabilities, Total
Total Liabilities 867.842 924.672 966.388 1015.34 941.634
Total Long Term Debt 373.202 419.42 443.431 442.413 429.453
Long Term Debt 373.202 419.42 443.431 442.413 429.453
Minority Interest 54.231 55 53.871 53.349 53.894
Other Liabilities, Total 64.607 74.312 85.903 86.027 75.218
Total Equity 1079.12 1051.57 1015.74 985.646 966.758
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.038 0.038 0.038 0.038 0.038
Additional Paid-In Capital 758.669 755.063 750.914 743.276 736.536
Retained Earnings (Accumulated Deficit) 782.918 757.672 725.955 700.313 670.734
Treasury Stock - Common -462.508 -461.2 -461.168 -457.981 -440.55
Total Liabilities & Shareholders’ Equity 1946.96 1976.24 1982.13 2000.99 1908.39
Total Common Shares Outstanding 32.5442 32.5183 32.4795 32.4325 32.5666
Deferred Income Tax 22.752 20.411 15.983 6.179 2.915
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 117.699 210.166 185.184 127.907 120.129
Cash From Operating Activities 133.283 188.893 288.952 202 223.483
Cash From Operating Activities 24.935 30.901 28.802 18.428 13.261
Deferred Taxes 23.377 44.582 -26.56 13.466 20.271
Non-Cash Items 72.316 34.262 75.304 73.555 26.84
Cash Taxes Paid 24.013 34.097 50.721 29.522 14.278
Cash Interest Paid 27.694 5.291 6.207 9.628 3.522
Changes in Working Capital -105.044 -131.018 26.222 -31.356 42.982
Cash From Investing Activities -94.486 -281.607 -287.108 -352.948 -22.193
Capital Expenditures -7.215 -6.721 -5.332 -7.888 -6.558
Other Investing Cash Flow Items, Total -87.271 -274.886 -281.776 -345.06 -15.635
Cash From Financing Activities -30.433 55.126 -14.977 227.209 -267.424
Financing Cash Flow Items -5.938 -81.187 4.385 -11.465 -10.093
Issuance (Retirement) of Stock, Net -11.199 -93.856 9.887 6.798 -173.381
Issuance (Retirement) of Debt, Net -13.296 230.169 -29.249 231.876 -83.95
Net Change in Cash 8.364 -37.588 -13.133 76.261 -66.134
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 24.909 117.699 86.153 60.75 31.713
Cash From Operating Activities 25.961 133.283 92.4 106.03 48.621
Cash From Operating Activities 5.694 24.935 19.705 14.228 8.008
Deferred Taxes 2.772 23.377 19.031 6.003 3.205
Non-Cash Items 15.923 72.316 59.271 39.156 20.809
Cash Taxes Paid 0.352 24.013 23.582 22.977 0.551
Cash Interest Paid 6.654 27.694 9.153 4.489 1.864
Changes in Working Capital -23.337 -105.044 -91.76 -14.107 -15.114
Cash From Investing Activities 45.896 -94.486 -92.62 -91.587 -16.079
Capital Expenditures -1.56 -7.215 -5.186 -3.341 -1.138
Other Investing Cash Flow Items, Total 47.456 -87.271 -87.434 -88.246 -14.941
Cash From Financing Activities -56.89 -30.433 -14.089 -11.448 -7.402
Financing Cash Flow Items -2.393 -5.938 -9.047 -4.785 -4.702
Issuance (Retirement) of Stock, Net 0.816 -11.199 -13.416 -14.688 1.071
Issuance (Retirement) of Debt, Net -55.313 -13.296 8.374 8.025 -3.771
Net Change in Cash 14.967 8.364 -14.309 2.995 25.14

Amedisys Company profile

About Amedisys Inc

Amedisys, Inc. is a healthcare services company, which is a multi-state provider of home health, hospice, and personal care services. The Company operates through three segments: Home Health, Hospice and Personal Care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 320 Medicare-certified home health care centers, 180 Medicare-certified hospice care centers and approximately 14 personal-care care centers in 39 states within the United States and the District of Columbia.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Amedisys Inc revenues increased 7% to $2.21B. Net income increased 14% to $209.1M. Revenues reflect Home Health Care segment increase of 8% to $1.35B, Hospice segment increase of 6% to $791.8M. Net income benefited from Home Health Care segment income increase of 21% to $271.7M, Other segment loss decrease of 5% to $185.5M.

Equity composition

Common Stock $.001 Par, 04/11, 60M auth., 30,084,676 issd., less 639,539 shs. in Treas. @ $14M. Insiders own 1.83%. 3/02, Exchangechanged from OTC Bulletin Board to NASDAQ. PO: 11/06, 3M shs. @ $41.5 per share by Raymond James. 12/06, 4-for-3 stock split.09/07, Name changed from Analytical Nursing Management.

Industry: Home Healthcare Services

3854 American Way Ste A
5959 S Sherwood Forest Blvd
BATON ROUGE
LOUISIANA 70816
US

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

US100

14,780.30 Price
+0.570% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

26,648.10 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

ETH/USD

1,598.70 Price
+0.380% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Oil - Crude

90.94 Price
+1.510% 1D Chg, %
Long position overnight fee 0.0349%
Short position overnight fee -0.0568%
Overnight fee time 21:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading